Equities research analysts forecast that CRH Medical Corporation (NASDAQ:CRHM) will announce $28.50 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for CRH Medical’s earnings. The lowest sales estimate is $28.30 million and the highest is $28.70 million. CRH Medical reported sales of $24.67 million in the same quarter last year, which would suggest a positive year over year growth rate of 15.5%. The business is expected to report its next earnings results on Monday, April 29th.
According to Zacks, analysts expect that CRH Medical will report full-year sales of $128.95 million for the current financial year, with estimates ranging from $125.45 million to $130.90 million. For the next financial year, analysts forecast that the company will report sales of $143.17 million, with estimates ranging from $132.40 million to $158.00 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for CRH Medical.
CRH Medical (NASDAQ:CRHM) last announced its earnings results on Wednesday, March 13th. The company reported $0.02 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.02. The firm had revenue of $32.02 million during the quarter, compared to analysts’ expectations of $31.40 million.
Shares of CRHM opened at $2.62 on Friday. CRH Medical has a twelve month low of $2.40 and a twelve month high of $4.50.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Featured Article: Why are gap-down stocks important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.